Oral Contraceptives and Melanoma Risk in Women
Author Information
Author(s): Karagas M R, Stukel T A, Dykes J, Miglionico J, Greene M A, Carey M, Armstrong B, Elwood J M, Gallagher R P, Green A, Holly E A, Kirkpatrick C S, Mack T, Østerlind A, Rosso S, Swerdlow A J
Primary Institution: Dartmouth Medical School
Hypothesis
Does the use of oral contraceptives increase the risk of melanoma in women?
Conclusion
The study found no significant association between oral contraceptive use and the risk of melanoma in women.
Supporting Evidence
- The pooled odds ratio for 'ever use' of oral contraceptives and melanoma was 0.86.
- There was no evidence of heterogeneity between studies.
- The risk of melanoma was unrelated to duration of use or age at first use.
- Adjustment for confounding factors did not significantly change the odds ratios.
- Findings were consistent across different study designs.
Takeaway
The study looked at many women to see if taking birth control pills made them more likely to get skin cancer called melanoma, and it found that it doesn't.
Methodology
The study pooled data from 10 case-control studies, analyzing the relationship between oral contraceptive use and melanoma risk using odds ratios.
Potential Biases
There may be biases related to the selection of cases and controls, as well as reporting biases in self-reported contraceptive use.
Limitations
The study may not account for all potential confounding factors and relied on self-reported data regarding oral contraceptive use.
Participant Demographics
The study included women diagnosed with melanoma and matched controls, with a total of 2391 cases and 3199 controls.
Statistical Information
P-Value
0.62
Confidence Interval
95% CI=0.74–1.01
Statistical Significance
p=0.62
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website